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T
he NIH has recently established a highly interactive consortium of 11 research groups on Enhancing
Development of Genome-wide Association Methods (ENDGAME) to advance the utility of genome-wide
association studies. The consortium (funded by the NHLBI, NIEHS, NCI, NHGRI, and NIGMS) brings
together expertise in genetics, epidemiology, biostatistics, and bioinformatics to develop and test innovative,
informative, and cost-effective study designs and analytical strategies for performing genome-wide association
studies on complex diseases. Available resources
such as the International Haplotype Mapping
(HapMap) data and single nucleotide
polymorphism (SNP) discoveries along with
improvements in genome technologies have
increased the feasibility of genome-wide
association studies for complex diseases.
However, it has become increasingly apparent
that a major barrier to successfully completing
these studies is a lack of both appropriate
analytical tools and understanding of which
study designs and computational methods are
most appropriate for particular study scenarios. 
The NIEHS is most interested in the
development of analytical tools and
approaches that would allow identification of
environmental components or covariates of
complex diseases in genome-wide association
studies. Although most common chronic
diseases are the result of complex interactions between genes (G)
and environmental (E) factors, most analytical approaches adopted
for whole genome scans do not incorporate interactive effects with
environmental factors. Studies have indicated that failure to
account for G × E interactions in complex disease association
analyses can decrease the power to find genetic disease loci and
underestimate both the genetic and environmental effects of the
disease. The NIEHS is therefore co-funding with the NCI two
applications in this consortium, led by Dr. Duncan Thomas of the
University of Southern California and Dr. Charles Kooperberg of
the Fred Hutchinson Cancer Center, that specifically focus on identifying study designs and analytical methods
that will enhance the possibility of identifying gene–gene and gene–environment interactions. All strategies and
tools developed through this consortium will be made available to the entire scientific community. The long-
term goals of ENDGAME are to accelerate the identification of genetic susceptibility factors in human disease
and the ultimate development of novel and individual disease prevention and treatment strategies through the
advancement of genome-wide association study methodologies. 
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